Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
11/2003
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/13/2003WO2003093512A1 Methods and compositions for the modification of nucleic acids
11/13/2003WO2003093258A2 Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003092680A1 New surfactant-based formulation containing triclabendazole
11/13/2003WO2003092624A2 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092583A2 Methods and compositions for treating ectoparasite infestation
11/13/2003WO2003068955A3 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/13/2003WO2003029213A9 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002094250A3 Therapeutic uses of lna-modified oligonucleotides in infectious diseases
11/13/2003WO2002058629A3 Stable aqueous antimicrobial suspension
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003US20030212091 Aryl ether substituted imidazoquinolines
11/13/2003US20030211964 Method of inhibiting pathogenicity of infectious agents
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003CA2736019A1 Methods and compositions for treating ectoparasite infestation
11/13/2003CA2485098A1 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003CA2484940A1 Methods and compositions for the modification of nucleic acids
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/12/2003EP1360304A2 Enzymes
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1359930A2 Novisprins: antimicrobial peptides
11/12/2003EP1359912A2 Novel methods using pyridine derivatives
11/12/2003CN1455815A Malaria plasmodium antigen polypeptide SE36, method of purifying same and vaccine and diagnosis with use of obtained antigen
11/12/2003CN1454901A Gynaecological anti-infective specificity IgY and its combined preparation
11/12/2003CN1127508C Polyene antibiotics 3874 H1-H6, preparation method and use thereof
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/12/2003CN1127294C Endoparasiticidal and ectoparasiticidal agents
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6645966 Reverse malaria drug resistance
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/06/2003WO2003090774A1 Mannose binding lectin and uses thereof
11/06/2003WO2003090757A1 Pharmaceutical compositions of phospholipid derivatives
11/06/2003WO2003079981A3 Bioadhesive drug delivery system
11/06/2003WO2003055880A3 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003016354A3 Recombinant anti-plasmodium falciparum antibodies
11/06/2003WO2002080895A3 Treatment of malaria with farsenyl protein transferase inhibitors
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208041 Chloride channel polypeptides and nucleic acids, and their uses in obtaining compounds for preventing or treating a tick infestation
11/06/2003US20030207870 Aryl ureas with angiogenisis inhibiting activity
11/06/2003US20030207869 Method for controlling pests, characterized in that at least one compound of the formula (I) according to claim 1 or a pesticide according to claim 7 is allowed to act on pests and/ or their habitat.
11/06/2003US20030207798 Hair growth promoting agent including a cyclosporin derivative as an active ingredient, and more particularly, a hair growth promoting agent including a cyclosporin A derivative substituted in the 3-position as an active ingredient.
11/06/2003CA2483441A1 Mannose binding lectin and uses thereof
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358183A2 Cysteine protease inhibitors
11/05/2003EP1358176A2 Inhibitors of cruzipain and other cysteine proteases
11/05/2003EP1358174A2 Inhibitors of cruzipain and other cysteine proteases
11/05/2003EP1357932A1 Crystal modification of a cyclic depsipeptide having improved strength
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454096A Activity of extract of piper betle leaves against leishmania
11/05/2003CN1452976A Compound glucose injection with clindamycin and metronidazole
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642206 Monocyclic L-nucleosides, analogs and uses thereof
11/04/2003CA2296109C Improved process for antiparasitic agent
11/04/2003CA2272483C Pyrazoles
10/2003
10/30/2003WO2003089593A2 Adjuvant enhanced immunotherapy
10/30/2003WO2003089577A2 Antihelminthic anthraquinones and method of use thereof
10/30/2003WO2003089006A1 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/30/2003WO2003088995A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003051294A3 Mitocidal compositions and methods
10/30/2003WO2003045319A3 Targeted therapeutics and uses thereof
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003US20030203961 A taxane joined by a hydrolyzable bond to one or more oligomers that containing a polyethylene glycol group and a tert-amide group
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203908 A triazine enzyme inhibitors for treating malaria, parasite disease, Chagas' disease, sleep disorder or Toxoplasma goudii; chemical intermediate synthesis
10/30/2003US20030203891 A veterinary medicine for controlling parasites and pests on animals
10/30/2003US20030203859 A combination of a bis-aryl compound (such as fipronil) and an avermectin or milbemycin or derivative useful as parasitic agent
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203848 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203378 Based on identification of species specific 5' hinge and 3' hinge regions of U3 small nucleolar ribonucleic acid (snoRNA)
10/30/2003US20030202997 Killing parasites with fatty ester and organosilicon compound
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482593A1 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482022A1 Novel compounds
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356733A2 Pesticidal and antiparasitic compositions
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 218